The use of blood biomarkers to predict radiation lung toxicity: A potential strategy to individualize thoracic radiation therapy

Cancer Control

Volumn 15, Issue 2, 2008, Pages 140-150

  Kong, Feng Ming ^a   Ao, Xiaoping ^a   Wang, Li ^a   Lawrence, Theodore S ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYTOCHROME P450 2D6; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; KL 6 ANTIGEN; REACTIVE OXYGEN METABOLITE; SURFACTANT ASSOCIATED PROTEIN; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D; THROMBOMODULIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR ANTIGEN; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

BLOOD; BLOOD CHEMISTRY; CANCER RADIOTHERAPY; CLINICAL ASSESSMENT; DNA REPAIR; DOSIMETRY; ELECTROSPRAY MASS SPECTROMETRY; GENETIC POLYMORPHISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTERSTITIAL PNEUMONIA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; MOLECULAR MECHANICS; NONHUMAN; PARTIAL BODY RADIATION; PREDICTOR VARIABLE; PROTEIN ANALYSIS; PROTEOMICS; RADIATION INJURY; RADIATION PNEUMONIA; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; THORAX RADIOTHERAPY;

EID: 49649100905     PISSN: 10732748     EISSN: 15262359     Source Type: Journal    
DOI: 10.1177/107327480801500206     Document Type: Review

References (47)

1. Kong FM, Ten Haken RK, Schipper MJ, et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/ unresectable non-small-cell lung cancer: long term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys. 2005;63:324-333.
2. MacKay RI, Niemierko A, Goitein M, et al. Potential clinical impact of normal-tissue intrinsic radiosensitivity testing. Radiother Oncol. 1998;46:215-216.
3. Kong FM, Ten Haken R, Eisbruch A, et al. Non-small cell lung cancer therapy-related pulmonary toxicity: an update on radiation pneumonitis and fibrosis. Semin Oncol. 2005;32(2 suppl 3):S42-54.
4. Kong FM, Pan C, Eisbruch A, et al. Physical models and simpler dosimetric descriptors of radiation late toxicity. Semin Radiat Oncol. 2007;17:108-120.
5. Kong FM, Hayman JA, Griffith KA, et al. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys. 2006;65:1075-86. Epub 2006 May 2.
6. Svensson JP, Stalpers LJ, Esveldt-van Lange RE, et al. Analysis of gene expression using gene sets discriminates cancer patients with and without late radiation toxicity. PLoS Med. 2006;3:e422.
7. Andreassen CN, Alsner J, Overgaard J. Does variability in normal tissue reactions after radiotherapy have a genetic basis: where and how to look for it? Radiother Oncol. 2002;64:131-140.
8. Marks LB, Yu X, Vujaskovic Z, et al. Radiation-induced lung injury. Semin Radiat Oncol. 2003;13:333-345.
9. Fleckenstein K, Gauter-Fleckenstein B, Jackson IL, et al. Using biological markers to predict risk of radiation injury. Semin Radiat Oncol. 2007;17:89-98.
10. Rubin P, Johnston CJ, Williams JP, et al. A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys. 1995;33:99-109.
11. Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med. 2001;345:517-525.
12. Hashimoto N, Jin H, Liu T, et al. Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest. 2004;113:243-252.
13. Phillips RJ, Burdick MD, Hong K, et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest. 2004;114:438-446.
14. Epperly MW, Guo H, Shields D, et al. Correlation of ionizing irradiation-induced late pulmonary fibrosis with long-term bone marrow culture fibroblast progenitor cell biology in mice homozygous deletion recombinant negative for endothelial cell adhesion molecules. In Vivo. 2004;18:1-14.
15. Epperly MW, Guo H, Gretton JE, et al. Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis. Am J Respir Cell Mol Biol. 2003;29:213-224. Epub 2003 Mar 20.
16. Rübe CE, Wilfert F, Uthe D, et al. Increased expression of pro-inflammatory cytokines as a cause of lung toxicity after combined treatment with gemcitabine and thoracic irradiation. Radiother Oncol. 2004;72:231-241.
17. Anscher MS, Peters WP, Reisenbichler H, et al. Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl J Med. 1993;328:1592-1598.
18. Fu XL, Huang H, Bentel G, et al. Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta. Int J Radiat Oncol Biol Phys. 2001;50:899-908.
19. Anscher MS, Kong FM, Andrews K, et al. Plasma transforming growth factor beta1 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys. 1998;41:1029-1035.
20. Kong F, Jirtle RL, Huang DH, et al. Plasma transforming growth factor-beta1 level before radiotherapy correlates with long term outcome of patients with lung carcinoma. Cancer. 1999;86:1712-1719.
21. Anscher MS, Marks LB, Shafman TD, et al. Using plasma transforming growth factor beta-1 during radiotherapy to select patients for dose escalation. J Clin Oncol. 2001;19:3758-3765.
22. Anscher MS, Marks LB, Shafman TD, et al. Risk of long-term complications after TGF-beta1-guided very-high-dose thoracic radiotherapy. Int J Radiat Oncol Biol Phys. 2003;56:988-995.
23. Kong FM, Anscher MS, Sporn TA, et al. Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor (M6P/IGF2R) locus predisposes patients to radiation-induced lung injury. Int J Radiat Oncol Biol Phys. 2001;49:35-41.
24. Barthelemy-Brichant N, Bosquée L, Cataldo D, et al. Increased IL-6 and TGF-beta1 concentrations in bronchoalveolar lavage fluid associated with thoracic radiotherapy. Int J Radiation Oncology Biol Phys. 2004;58:758-767.
25. Vujaskovic Z, Groen HJ. TGF-beta, radiation-induced pulmonary injury and lung cancer. Int J Radiat Biol. 2000;76:511-516.
26. De Jaeger K, Seppenwoolde Y, Kampinga HH, et al. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004;58:1378-1387.
27. Novakova-Jiresova A, Van Gameren MM, Coppes RP, et al. Transforming growth factor-beta plasma dynamics and post-irradiation lung injury in lung cancer patients. Radiother Oncol. 2004;71:183-189.
28. Anscher MS, Kong FM. In regard to De Jaeger et al.: significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer (Int J Radiat Oncol Biol Phys. 2004;58:1378-1387). Int J Radiat Oncol Biol Phys. 2005;61:1276-1277.
29. Zhao L, Sheldon K, Chen M, et al. The predictive role of plasma TGF-beta1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer. Lung Cancer. 2008;59(2):232-239. Epub 2007 Oct 1.
30. Anscher MS, Kong FM, Marks LB, et al. Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis. Int J Radiat Oncol Biol Phys. 1997;37;253-258.
31. Chen Y, Hyrien O, Williams J, et al. Interleukin (IL)-1A and IL-6: applications to the predictive diagnostic testing of radiation pneumonitis. Int J Radiat Oncol Biol Phys. 2005;62:260-266.
32. Chen Y, Williams J, Ding I, et al. Radiation pneumonitis and early circulatory cytokine markers. Semin Radiat Oncol. 2002;12(1 suppl 1):26-33.
33. Arpin D, Perol D, Blay JY, et al. Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis. J Clin Oncol. 2005;23:8748-8756.
34. Hauer-Jensen M, Kong FM, Fink LM, et al. Circulating throbomodulin during radiation therapy of lung cancer. Radiat Oncol Invest. 1999;7:238-242.
35. Healy AM, Hancock WW, Christie PD, et al. Intravascular coagulation activation in a murine model of thromobomodulin deficiency: effects of lesion size, age, and hypoxia on fibrin deposition. Blood. 1998;92:4188-4197.
36. Goto K, Kodama T, Sekine I, et al. Serum levels of KL-6 are useful biomarkers for severe radiation pneumonitis. Lung Cancer. 2001;34:141-148.
37. Hara R, Itami J, Komiyama T, et al. Serum levels of KL-6 for predicting the occurrence of radiation pneumonitis after stereotactic radiotherapy for lung tumors. Chest. 2004;125:340-344.
38. Rubin P, McDonald S, Maasilta P, et al. Serum markers for prediction of pulmonary radiation syndromes. Part I: Surfactant apoprotein. Int J Radiat Oncol Biol Phys. 1989;17:553-558.
39. Matsuno L, Satoh H, Ishikawa H, et al. Simultaneous measurement of KL-6 and SP-D in patients undergoing thoracic radiotherapy. Med Oncol. 2006;23:75-82.
40. Sasaki R, Soejima T, Matsumoto A, et al. Clinical significance of serum pulmonary surfactant proteins A and D for the early detection of radiation pneumonitis. Int J Radiat Oncol Biol Phys. 2001;50:301-307.
41. Hart JP, Broadwater G, Rabbani Z, et al. Cytokine profiling for prediction of symptomatic radiation-induced lung injury. Int J Radiat Oncol Biol Phys. 2005;63:1448-1454. Epub 2005 Aug 22.
42. Ménard C, Johann D, Lowenthal M, et al. Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis. Cancer Res. 2006;66:1844-1850.
43. Ao X, Lubman DM, Davis MA, et al. Comparative proteomic analysis of radiation-induced changes in mouse lung: fibrosis sensitive vs resistant strains. Radiat Res. In Press.
44. Damaraju S, Murray D, Dufour J, et al. Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer. Clin Cancer Res. 2006;12:2545-2554.
45. Chang-Claude J, Popanda O, Tan XL, et al. Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin Cancer Res. 2005;11:4802-4809.
46. Zhang L, Wang M, Yang D, et al. Association of DNA repair and inflammatory cytokines gene polymorphisms with radiation-induced toxicity in lung cancer. Int J Radiat Oncol Biol Phys. 2007;69:S60-S61.
47. McShan DL, Tu S, Rubin D, et al. Knowledge-based approach to management of Image Guided Radiation Therapy. Presented at the Bioengineering & Imaging Research Opportunities Workshop (BIROW) IV. Bethesda, MD. Feb 24-25, 2006.